Jan Schmidt-Brand will lead the executive management board of Wilex AG from 1 April following the resignation of Olaf Wilhelm, the company’s co-founder and chief executive officer. Dr Schmidt-Brand is currently chief financial officer. Following a recent restructuring, Wilex has reduced the scope of its business and in future will focus on contract research services including the provision of technology for antibody-drug conjugates.
Dr Schmidt-Brand has served for many years in commercial and financial roles in the pharmaceutical industry. He was both CEO and CFO of Heidelberg Pharma AG which was acquired by Wilex in 2010.
Wilex announced the appointment on 24 February 2014.
Copyright 2014 Evernow Publishing Ltd.